Niaspan

Pellagra, Hardening of the Arteries, dietary supplementation + 14 more

Treatment

8 FDA approvals

20 Active Studies for Niaspan

What is Niaspan

Niacin

The Generic name of this drug

Treatment Summary

Niacin is a B vitamin used to replenish vitamin deficiencies and reduce the levels of fats in the bloodstream. It can also help reduce the risk of heart attacks.

O-Cal FA multivitamin

is the brand name

image of different drug pills on a surface

Niaspan Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

O-Cal FA multivitamin

Niacin

1970

106

Approved as Treatment by the FDA

Niacin, also known as O-Cal FA multivitamin, is approved by the FDA for 8 uses which include High Cardiovascular Risk and Hyperlipidemia .

High Cardiovascular Risk

Used in combination with other therapies

Hyperlipidemia

Used in combination with Sevelamer to help manage Hyperlipidemias

Hardening of the Arteries

Used in combination with Sevelamer to help manage Atherosclerosis

High Cholesterol

Used in combination with Sevelamer to help manage Hyperlipidemias

Coronary Artery Disease

Used in combination with Sevelamer to help manage history of coronary artery disease

dietary supplementation

Used in combination with Niacin for dietary supplementation

Primary Hypercholesterolemia

Used in combination with other therapies

Dietary Modifications

Used in combination with other therapies

Effectiveness

How Niaspan Affects Patients

Niacin is a B vitamin used to treat vitamin deficiencies and certain types of high cholesterol. It helps to lower the bad types of cholesterol (very low density lipoproteins and low density lipoproteins) and increase the good type (high density lipoproteins). Usually 500-2000mg is taken orally each day, but some people (those with diabetes, kidney problems, hypothyroidism, or elderly people taking niacin with simvastatin or lovastatin) are at risk of muscle problems like myopathy and rhabdomyolysis.

How Niaspan works in the body

Niacin helps reduce your levels of lipids and proteins that contain lipids, like apolipoprotein B (apo B). It does this by restricting the production of triglycerides in the liver, which also reduces apo B levels. Niacin also stops the breakdown of a type of protein called high density lipoprotein (HDL), which leads to higher levels and longer life of HDL.

When to interrupt dosage

The prescribed amount of Niaspan is reliant upon the diagnosed condition, for example inadequate response to diet, Dietary Modifications and Pellagra. The degree of dosage changes depending on the method of delivery (e.g. Oral or Tablet - Oral) detailed in the table beneath.

Condition

Dosage

Administration

Coronary Artery Disease

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Combined Modality Therapy

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Dietary Modifications

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Risk of pancreatitis

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

inadequate response to diet

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Hypertriglyceridemia

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

High Cholesterol

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Hardening of the Arteries

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

dietary supplementation

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Primary Hypercholesterolemia

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

cholesterol

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Myocardial Infarction

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Hyperlipidemias

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Triglycerides

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Dyslipidemias

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Pellagra

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

High Cardiovascular Risk

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Warnings

Niaspan Contraindications

Condition

Risk Level

Notes

Hypervitaminosis

Do Not Combine

Liver Dysfunction

Do Not Combine

Transaminases

Do Not Combine

Hemorrhage

Do Not Combine

Liver Diseases

Do Not Combine

Peptic Ulcer

Do Not Combine

Transaminases

Do Not Combine

There are 20 known major drug interactions with Niaspan.

Common Niaspan Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be decreased when combined with Niacin.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be decreased when combined with Niacin.

Acenocoumarol

Major

The metabolism of Acenocoumarol can be decreased when combined with Niacin.

Alectinib

Major

The metabolism of Alectinib can be decreased when combined with Niacin.

Alpelisib

Major

The metabolism of Alpelisib can be decreased when combined with Niacin.

Niaspan Toxicity & Overdose Risk

An overdose of niacin can cause prolonged low blood pressure. If this occurs, supportive treatments such as giving fluids intravenously may be necessary. In mice, the toxic dose of niacin is 3720mg/kg, in rabbits it is 4550mg/kg, in rats it is 7000mg/kg, and in rats the toxic dose when applied to the skin is higher than 2000mg/kg.

image of a doctor in a lab doing drug, clinical research

Niaspan Novel Uses: Which Conditions Have a Clinical Trial Featuring Niaspan?

At present, 44 active trials are underway to assess the potential of Niaspan to address inadequate dietary responses, Cholesterol elevation and Type II Hyperlipidaemia.

Condition

Clinical Trials

Trial Phases

Coronary Artery Disease

0 Actively Recruiting

dietary supplementation

0 Actively Recruiting

High Cholesterol

19 Actively Recruiting

Phase 2, Phase 3, Not Applicable, Early Phase 1

Dyslipidemias

1 Actively Recruiting

Phase 2

Pellagra

0 Actively Recruiting

cholesterol

4 Actively Recruiting

Phase 3, Not Applicable

Hyperlipidemias

0 Actively Recruiting

Risk of pancreatitis

0 Actively Recruiting

Hardening of the Arteries

17 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Phase 3

Primary Hypercholesterolemia

8 Actively Recruiting

Phase 2, Phase 3, Not Applicable

Combined Modality Therapy

0 Actively Recruiting

High Cardiovascular Risk

1 Actively Recruiting

Phase 3

Dietary Modifications

3 Actively Recruiting

Early Phase 1, Not Applicable, Phase 2

Triglycerides

0 Actively Recruiting

Hypertriglyceridemia

6 Actively Recruiting

Phase 3, Phase 2

Myocardial Infarction

0 Actively Recruiting

inadequate response to diet

0 Actively Recruiting

Niaspan Reviews: What are patients saying about Niaspan?

5

Patient Review

6/26/2012

Niaspan for High Cholesterol

I was on this drug for about 4 months. Did nothing for my Cholesterol level. Never got over the burning from the inside out, extreme redness, and itching.

5

Patient Review

8/12/2013

Niaspan for Combined High Blood Cholesterol and Triglyceride Level

I saw a significant reduction in cholesterol and triglyceride levels after just four months of using this medication, and my HDL level also increased. I'm very pleased with the results.

5

Patient Review

1/27/2015

Niaspan for Combined High Blood Cholesterol and Triglyceride Level

Niaspan has been effectively keeping my levels in a good range for nine years now. Welchol was added two years ago and my cholesterol levels are now normal. Plus, my HDL is above 80 and T-Chol/HDL is below 3.5

5

Patient Review

9/13/2014

Niaspan for Combined High Blood Cholesterol and Triglyceride Level

I have been taking this medication for a long time and have had great results. My blood work is always clean and my doctor is happy with the results. However, I am starting to become concerned with some of the recent studies that have come out.

4.7

Patient Review

7/26/2012

Niaspan for Combined High Blood Cholesterol and Triglyceride Level

I have been on Niaspan for a few years now and I am beginning to wonder if it is causing more harm than good. I have noticed that injuries are more easily obtained and last longer, as well as different side effects such as burning in the sides of my heels, nausea, vomiting, upset stomach, and pain in the bottom of my feet. The numbers seem to be helpful, but I'm just concerned that it's ruining me in some way.

4.3

Patient Review

7/27/2013

Niaspan for Combined High Blood Cholesterol and Triglyceride Level

I've experienced some strange things since starting to use Niaspan. My legs feel weak and painful, and I've been hiccupping for days now with no relief in sight. I'm going to stop taking the medication for a while and see if these symptoms go away. Statins are worse, so I didn't want to read about side effects until now in case I started experiencing them myself.

4.3

Patient Review

8/8/2012

Niaspan for High Amount of Triglyceride in the Blood

I started taking Niaspan in April 2012. My total cholesterol was 270 and my bad cholesterol was 160. After eight weeks of taking the medication, along with oat bran, my total cholesterol was 202 and my bad cholesterol was 131. I highly recommend this book to anyone seeking similar results."

3.7

Patient Review

11/9/2012

Niaspan for Combined High Blood Cholesterol and Triglyceride Level

I took this medication for six months at a dosage of 500mg per day, and then increased it to 1000mg. My cholesterol levels have lowered somewhat, but I've been dealing with really uncomfortable burning and tingling skin. Additionally, my blood sugar has risen above what is considered normal.

3.3

Patient Review

6/6/2012

Niaspan for Combined High Blood Cholesterol and Triglyceride Level

3

Patient Review

10/16/2012

Niaspan for High Cholesterol

I had been taking this medication for a few weeks with no issues until last night. I woke up to my insides burning and it lasted around half an hour. It was so severe that I'm seeing my doctor in the morning. Even though this drug has helped me a lot (my triglycerides dropped from 250 to 91), I don't know if I can continue taking it.

2.3

Patient Review

4/1/2019

Niaspan for High Cholesterol

One possible side effect of this medicine is blotchy skin, which I unfortunately experienced. Now, I have what look like age spots on my legs.

1.7

Patient Review

5/11/2013

Niaspan for High Cholesterol

I took the 500 mg dosage for 8 days as recommended. However, I started to feel really tired and achy; I attributed this to the statins I had just stopped taking. Then, as per my doctor's orders, I went up to 1000 mg. Immediately, I felt even more lethargic and out of it. Not to mention, my urine became discolored after only 5 days. So,I stopped taking it and gradually the aches and fatigue went away.

1.7

Patient Review

9/14/2012

Niaspan for Low HDL Cholesterol

I found this medication to be effective; it did what it said it would do. I took 1000 MG from the beginning, only at night before bed. I didn't experience any flushing but occasionally felt a twisted feeling. I'm in a different country now and my new doctor says this drug is experimental, very expensive, and not stocked by hospitals. We will monitor my LDL and triglyceride levels; if necessary, I will reorder the medication.

1.3

Patient Review

9/23/2013

Niaspan for Combined High Blood Cholesterol and Triglyceride Level

At first, I was on a lower dosage which didn't do much. So my doctor upped it to 1500mg... and then my liver enzymes and potassium levels went up. I was constantly throwing up and feeling very tired and lightheaded. My doctor took me off of the medication for 3 weeks to see how I would fare without it.

1

Patient Review

5/16/2012

Niaspan for High Cholesterol

1

Patient Review

6/1/2014

Niaspan for Combined High Blood Cholesterol and Triglyceride Level

I unfortunately had an allergic reaction to Niaspan 500mg where I developed hives.

1

Patient Review

2/5/2013

Niaspan for High Cholesterol

Recently, my doctor upped my dosage to 2000 mg a day. Since then, I've been incredibly tired and have struggled to get enough sleep. Has anyone else experienced this problem?

1

Patient Review

11/3/2016

Niaspan for Low HDL Cholesterol

I took Niaspan for one month and was okay. The second month, I started feeling a burning sensation on my legs which then spread to my arms. One night, it was so severe that I thought I might spontaneously combust. Thankfully, I stopped taking the drug immediately and saw a doctor who told me that I must be allergic to it.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about niaspan

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Niaspan a statin drug?

"Niaspan lowers triglycerides, but Mevacor is more effective for improving cholesterol levels. Statin side effects can be difficult to deal with, but the benefits might outweigh the risks."

Answered by AI

What is Niaspan 500mg used for?

"Niaspan is a medicine that you need a prescription for. It is used to lower the levels of bad cholesterol in your blood, and to increase the levels of good cholesterol. You can take it by itself, or with other medications."

Answered by AI

Is Niaspan the same as niacin?

"Niaspan is a medication that contains niacin, a type of B vitamin. Niaspan is used to lower cholesterol and triglycerides in the blood."

Answered by AI

What is the drug Niaspan used for?

"Niacin is a drug that helps to lower bad cholesterol and fats (LDL and triglycerides) in the blood and raise good cholesterol (HDL) when used in combination with a proper diet and exercise program. It is usually used after non-drug treatments have not been successful in lowering cholesterol levels."

Answered by AI

Clinical Trials for Niaspan

Image of University of Alberta in Edmonton, Canada.

Pharmacist-led Care for Diabetes

18+
All Sexes
Edmonton, Canada

As of 2024, nine percent of Albertans are living with Type 2 diabetes, which increases their risk for cardiovascular disease, stroke, blindness, and kidney failure. Unfortunately, less than half of patients have controlled Type 2 diabetes. We are well aware of the factors which lead to worsening diabetes, but need to give people more support to help them manage their diabetes. Pharmacists are respected health care professionals who are often easier to see that doctors and can help people with diabetes to stay as healthy as possible. This research project aims to see whether a pharmacist service can help improve diabetes management in people with type 2 diabetes compared to usual care from their family physician or nurse practitionner. The potential impact of this project is to empower people with type 2 diabetes to understand their condition, it's management, and to achieve target blood sugar levels, which will ultimately reduce the risk of diabetes-related complications.

Recruiting
Has No Placebo

University of Alberta

Ross Tsuyuki, BScPharm, PharmD, MSc

Have you considered Niaspan clinical trials?

We made a collection of clinical trials featuring Niaspan, we think they might fit your search criteria.
Go to Trials
Image of Lipid Clinic at Brown University Health in Providence, United States.

2-HOBA Supplementation for High Cholesterol

18 - 69
All Sexes
Providence, RI

The goal of this clinical trial is to learn if a natural supplement called 2-hydroxybenzylamine (2-HOBA) can reduce harmful oxidized lipids and improve the function of lipoprotein(a) in adults with high lipoprotein(a) levels. The main questions it aims to answer are: Does 2-HOBA lower oxidized phospholipids on lipoprotein(a)? Does 2-HOBA reduce markers of inflammation and blood clotting in the blood? Participants will: Take 2-HOBA capsules (400 mg, three times daily with meals) for 6 weeks Provide blood and urine samples at the beginning, middle, and end of the study Have lab tests to measure changes in lipids, inflammation, and clotting markers

Waitlist Available
Has No Placebo

Lipid Clinic at Brown University Health

Wenliang Song, MD

Have you considered Niaspan clinical trials?

We made a collection of clinical trials featuring Niaspan, we think they might fit your search criteria.
Go to Trials
Image of Sidney & Lois Eskenazi Hospital in Indianapolis, United States.

Composite Intervention for Metabolic Syndrome

18+
All Sexes
Indianapolis, IN

The objective of this study is to pilot a multifaceted, optimized intervention for metabolic syndrome (MetS) in emergency department patients to establish feasibility. Participants (n=20) will be randomized to intervention or control (usual care). The composite intervention will include an educational video outlining the adverse effects of MetS and the benefit of walking, a written exercise prescription with a defined goal of walking 150 minutes per week, a Fitbit accelerometer device, resources for healthy eating practices, periodic text message reminders, and an urgent referral to primary care and our health system's Healthy Me clinic for follow-up visit. Investigators hypothesize that this approach will change patient understanding and motivation to increase physical activity and healthy eating habits.

Recruiting
Has No Placebo

Sidney & Lois Eskenazi Hospital

Image of Duke University Medical Center in Durham, United States.

Cardiometabolic Prevention Clinic for Cardiovascular Disease

18+
All Sexes
Durham, NC

This project is studying whether a team-based specialty clinic can help people with type 2 diabetes and heart disease better manage their blood pressure and cholesterol. The clinic includes coordinated care from heart doctors, kidney doctors, diabetes specialists, and liver doctors. The study will compare two groups of patients: one receiving usual care from their primary care provider, and one referred to the Duke Cardiometabolic Prevention Clinic for multidisciplinary care. The main goals are to find out if this clinic improves blood pressure and cholesterol control over 12 months, increases use of recommended heart medications, and reduces hospital visits and other healthcare use. Participants will be randomly assigned to one of the two groups. Those referred to the clinic will: 1) Meet with a cardiologist for an initial evaluation. 2) Be referred to other specialists (such as endocrinology, nephrology, or hepatology) based on their needs. 3) Receive ongoing, coordinated care from a team of specialists working together to improve their heart and metabolic health.

Recruiting
Has No Placebo

Duke University Medical Center

Neha J Pagidipati, MD, MPH

Image of University of Alabama at Birmingham in Birmingham, United States.

Inspire HER for Cardiovascular Disease

30 - 79
Female
Birmingham, AL

Poor heart health puts Black women at risk for a shorter life with more illness than people of any other non-indigenous racial group. We will refine and conduct a randomized, wait-list controlled trial of Inspire HER (a heart health lifestyle intervention for Black women that provides health education, physical activity, and social resources). We will also compare Inspire HER and Black Impact (a heart health intervention for Black men) data to study how women and men respond differently to stress. This trial aligns with American Heart Association's pledge to address heart health equity through new interventions that consider the person and the circumstances with which they live.

Recruiting
Has No Placebo

University of Alabama at Birmingham

Timiya S Nolan, PhD

Image of Rush University Medical Center in Chicago, United States.

Health Coaching for Heart Disease

40 - 75
All Sexes
Chicago, IL

The goal of this longitudinal study is to investigate the role of virtual health coaching on mitigation of cardiometabolic disease risk in an underserved, food insecure population. The main questions it aims to answer are: * Does longitudinal, individualized health coaching directed at lifestyle modification reduce patient 10-year risk of heart attack or stroke? * Does longitudinal, individualized health coaching directed at lifestyle modification reduce rates of hypertension, hyperlipidemia, and diabetes? * Does longitudinal, individualized health coaching directed at lifestyle modification improve accessibility to healthcare? Researchers will investigate the effects of regularly scheduled health coaching sessions on composite cardiometabolic risk profile as well as individual modifiable cardiovascular risk factors. Participants will: * Participate in in-person cardiovascular screening, occuring at the time of enrollment, months 3 and 6. * Engage in virtual health coaching sessions to talk about diet, exercise, weight loss, blood pressure and diabetes control, and accessibility to healthcare * Keep a log of their blood pressure

Waitlist Available
Has No Placebo

Rush University Medical Center

Daniel Luger, MD

Have you considered Niaspan clinical trials?

We made a collection of clinical trials featuring Niaspan, we think they might fit your search criteria.
Go to Trials